touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 

touchPANEL DISCUSSION for touchHAEMATOLOGY 

Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 

touchPANEL DISCUSSION for touchDERMATOLOGY 

Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 

touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.

The experts

• Prof. Dr Vito Sabato, University of Antwerp, Antwerp, Belgium

This touchPODCAST is for HCPs outside of the UK only. 

This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME. 

For further information visit: 

Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.

The expert

• Prof. Heather A Wakelee – Stanford University, CA, USA

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.

Prof. Heather Wakelee discusses the use of immune checkpoint inhibitors for early-stage, resectable NSCLC, considering the most recent data on pre-, post- and peri-operative immunotherapy and their impact on clinical practice.

The expert

• Prof. Heather A Wakelee – Stanford University, CA, USA

This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Merck & Co., Inc. This activity is jointly provided by USF Health and touchIME.

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia

The multidisciplinary team and patient advocate:

MFM specialist - Prof. Karin Blakemore

Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

Paediatrician - Prof. Janet Legare

Patient advocate - Ms Carly Kutner

This touchPODCAST is for HCPs only.

For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications

The multidisciplinary team and patient advocate:

Paediatrician - Prof. Janet Legare

Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

Patient advocate - Ms Carly Kutner

This touchPODCAST is for HCPs only.

For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

touchMDT for touchENDOCRINOLOGY

Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications.

The multidisciplinary team and patient advocate:

Paediatrician - Prof. Janet Legare

MFM specialist - Prof. Karin Blakemore

Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

Patient advocate - Ms Carly Kutner

This touchPODCAST is for HCPs only.

For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/

touchMDT for touchENDOCRINOLOGY

Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals

The multidisciplinary team:

Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike 

MFM specialist - Prof. Karin Blakemore

Paediatrician - Prof. Janet Legare

This touchPODCAST is for HCPs only.

For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/